NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional) 2026-2029

NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional) 2026-2029

NIH’s PA-26-002 is a major federal mechanism for researchers who want a structured international collaboration model: a domestic U.S.-led award with separately funded and reviewed foreign linked subprojects. The NOFO title is NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional) and it was posted on 20 January 2026. The opportunity is open for the 2026 and 2027 application cycles with recurring NIH standard deadlines through at least early 2029 and an overall expiration date of 8 May 2029.

This mechanism is different from a standard single-site grant. It is a multi-component architecture: one Overall component, one or more domestic Research Project components, and required foreign-linked International Project components. It is aimed at projects where the project’s scientific value depends on resources, cohorts, environments, or partnerships that require collaboration with non-U.S. institutions. If you are a U.S.-based team with clear, non-U.S. scientific contribution needs, this can be one of the few NIH instruments built specifically for that use case.

At-a-glance summary

What this opportunity is and what it is not

This is a domestic prime + foreign linked award model. NIH uses the PF5 structure to support international collaborations where the U.S. side and foreign side are both formally funded and later disaggregated into linked awards. The NOFO is explicit that this is for funded collaborations, not loose technical exchange.

What the opportunity is:

• A U.S.-anchored grant pathway under NIH PF5.
• A mechanism to support international team science with formal foreign subawards/linked awards.
• A platform for scientifically distinct, multi-project applications when the collaboration cannot be done responsibly without international components.
• A 2026-2029 recurring-cycle opportunity with multiple submission deadlines and long runway.

What it is not:

• Not open to non-U.S. institutions applying as prime applicants.
• Not for projects using foreign consultants, foreign equipment procurement, or international activity that does not lead to funded foreign subawards.
• Not a fully pre-priced or fixed-value program; there is no single published total budget amount for this NOFO.
• Not a “no-registration” grant where you can just upload PDFs and submit; compliance is strict and non-compliant applications can fail review.

The NOFO says this mechanism specifically enables a domestic award with linked foreign projects assigned their own NoA context and linked handling. If your project logic is genuinely two-way science with clear foreign deliverables, this is aligned. If the collaboration is only advisory, this is likely a poor fit.

Who it fits best

This mechanism generally fits teams with projects requiring international scientific infrastructure, populations, natural experiments, or environments unavailable in the U.S., while maintaining a U.S. lead and shared oversight.

Good fit profiles:

• University research teams, academic health centers, and biomedical entities needing foreign cohorts or comparative cohorts.
• NIH-funded communities where a U.S. PI must coordinate with one or more foreign institutions at proposal and award stages.
• Large interdisciplinary projects with complexity better represented in separate components.
• Teams planning long-duration biology, translational, or clinical work where foreign partners provide critical execution capacity.

Also good fit when:

• You can justify the added complexity of multi-component planning.
• The foreign partner contributes essential scientific work, not just optional side support.
• You can manage the administrative load of a linked award structure.
• The team has a realistic PI leadership structure and can complete required registrations in advance.

Potential non-fit:

• Single-site pilots without formal non-U.S. scientific components.
• Groups without time for application orchestration across multiple components.
• Teams with incomplete registrations close to deadlines.
• Principal investigators without established eRA Commons and grants administration readiness.

Eligibility in practical terms

The NOFO eligibility list is broad on the U.S. side but strict on what it allows in role and structure:

• Eligible applicant organizations include U.S. higher education institutions, nonprofits, businesses, local/state/federal entities, tribal entities, regional organizations, and related covered categories.
• Non-domestic entities cannot apply directly.
• At least one International Project component is required.
• Foreign components are allowed as part of the structure, but they must be properly included under the PF5 design.
• Foreign entities are not expected to submit as the primary organization.

This distinction matters in pre-application planning. If you are from a U.S. institution but partner internationally, you are in scope. If your lead applicant is non-U.S., you are out of scope for this NOFO.

PD/PI eligibility and role requirements are also explicit:

• All PD(s)/PI(s) must have an eRA Commons account.
• Applicants should ensure the PI and organizational officials coordinate registration and role setup.
• For those serving in multiple roles (e.g., PI and signing official), separate eRA Commons roles may be needed.
• Multiple PIs are allowed within NIH rules, but you must follow NIH’s multi-PD/PI policy.

A critical strategic point: because foreign components become linked RF2 components if funded, each Project Leader for foreign subprojects also needs strong PI-level capacity and must satisfy eRA Commons requirements tied to their foreign organization.

Funding amount, award parameters, and support size

A common question is the amount. Unlike many NOFOs with fixed project caps, this NOFO does not set a fixed dollar limit in the published fields. The published award language says application budgets are not capped and should be driven by the actual needs of the project.

So for frontmatter amount, do not guess. Instead, evaluate funding level through the grant package and post-award conversations with the assigned institute/center.

What is confirmed:

• Application budgets are not statically capped in this call.
• Maximum project period: up to 5 years generally, up to 7 years if clinical trials are involved.
• Number and size of awards depends on NIH appropriations and quality/volume of meritorious applications.
• Clinical trials are optional.

How this affects your proposal strategy:

• Build a budget that is internally coherent and NIH-policy compliant.
• Tie each expense stream to component-level tasks.
• Avoid overinflating international costs unless those elements are essential and justified.
• Include robust international workstreams so the model cannot be reduced to domestic-only work.

If your project is highly resource-demanding, use componentized budget logic:

• Domestic Research Project component: U.S. science and coordination costs.
• International Project component: foreign-site execution costs.
• Optional core/ICDT components: only if mission-critical and administratively justified.

Application mechanics and timeline planning

Key dates and submission cadence

The posted NOFO includes recurring NIH standard cycles:

• posted date: 20 Jan 2026
• open date: 25 Apr 2026
• recurring NIH standard due dates through at least Jan 2029
• all due dates at 5:00 PM local time of the applicant organization
• expiration date: 8 May 2029

First practical deadline for many teams is 25 May 2026. Even though deadlines recur, this first one is usually the easiest target for teams that can pre-build and coordinate registration early.

Submission pathways

NIH requires electronic submission via Grants.gov, with either:

• ASSIST, or
• a compliant institutional system-to-system (S2S) route.

Paper applications are not accepted.

Core component structure

Applications must include components with specific instructions:

• Overall (required)
• Research Project (required)
• International Project (required)
• Core and ICDT components optional and only for specific complex structures

Each component has page limits. The Overall component requires a 12-page narrative in this NOFO context; Research Project is also 12 pages; International Project is 6 pages.

Application documentation priorities

The NOFO provides a heavy emphasis on integrated rationale:

• Overall: why the international collaboration is essential, not optional.
• Research Project: scientific rationale and innovation.
• International Project: specific roles, outputs, and local strengths of the foreign partner(s).

A strong PF5 application should read as one coherent scientific system, not three unrelated subproposals.

Registration and compliance prerequisites

This is where many proposals fail late:

• SAM.gov registration (active, with UEI/CAGE expectations in place).
• eRA Commons registration with signing official and PI details.
• Grants.gov registration.
• All of the above before submission.

The NOFO explicitly warns that registration delays are common and often not a valid reason for late submission. Some registrations can take up to about six weeks.

Also important:

• PD(s)/PI credentials must be in the senior/key person profile.
• The application can be rejected for non-compliance in form completion, not only for scientific quality.
• All corrections must be submitted by the deadline; corrected late files submitted after the due date are treated as late.

Review process and reviewer lens

The NOFO’s review process follows standard NIH peer-review sequencing:

• NIH Scientific Review Group review on scientific and technical merit.
• Written critique after review.
• Select applications may move to additional review and advisory level.
• Funding decisions incorporate merit, funds availability, and relevance to NIH IC priorities.

For applicants, this means there are two strong requirements:

1. Scientific clarity and plausibility.
2. NIH-mission fit for both the domestic lead and linked international project.

Budget reasonableness and period justification are also explicitly review criteria, and the mechanism’s linked-structure means reviewers look at both scientific quality and whether the international component is actually integral.

Practical checklist for a strong PF5 package

1) Confirm this is truly a collaborative international science problem

If the foreign partner is peripheral, the application likely becomes a poor fit. Use this test:

• Would the same question be answerable without the foreign site?
• Does the foreign site have unique access, data sources, methods, or settings central to the science?
• Are outputs from each side needed to complete the proposed work?

If answer is mostly “yes,” this mechanism is conceptually right.

2) Design the 3-tier story around fit

Build a single narrative across three sections:

• Problem and significance.
• Domestic leadership and responsibilities.
• Internationally required activities and expected added value.

The final proposal should not look like two disconnected projects stitched together.

3) Align with the PI and organizational governance model

Because roles are checked for PI credentials, authority, and Commons access, you must align:

• Who is PI on U.S. side.
• Who is project lead on each International Project.
• Whether each lead has required account and approval rights.

4) Use the review lens as a drafting frame

Draft each section as if scored by four lenses:

• Scientific merit.
• Feasibility of international execution.
• Budget realism across components.
• NIH mission and ICO relevance.

5) Build your compliance runway backward from due date

Treat compliance like a deliverable stream:

• Day -60 to -45: finalize registrations.
• Day -30 to -14: freeze required forms.
• Day -7 to -3: run dry-run submission and eRA Commons credential checks.
• Day -2 onward: final checks, then submit early.

The NOFO repeatedly emphasizes early submission to avoid platform corrections after finalization.

Common mistakes and avoidable failure points

• Forgetting that foreign entities cannot be the direct applicant.
• Missing the required international subproject while claiming foreign relevance.
• Submitting separate science that does not integrate across components.
• Omitting full registration requirements and then waiting until review time to fix account issues.
• Failing to include required eRA Commons IDs in PD/PI credential fields.
• Exceeding page limits or mixing required and optional components.
• Treating this as a standard single-project narrative.
• Late submission or failed change correction before due date.

If your institution is new to NIH systems, assign one operations lead solely for submission compliance and one science lead for narrative quality.

FAQ

Is PA-26-002 still suitable for teams starting now?

The NOFO is posted with recurring 2026–2029 due dates and has an expiration in 2029, so it is designed for multiple upcoming cycles. Use the official page to confirm the active current cycle before submitting.

Is this only for certain diseases or institutes?

Applications should align with the mission of participating NIH Institutes and Centers. The NOFO lists participating ICs broadly, and your project should map clearly to their priorities.

Can international teams receive direct funding under this structure?

Yes, via the linked international components (disaggregated RF2 structure) as part of the PF5 framework, not by applying as a standalone foreign applicant.

Is cost sharing required?

The NOFO states no cost sharing is required.

Can I apply with a renewal or revision?

Renewal and revision options are allowed for PF5 awards as specified by NIH application-type rules; new applications are the default route.

What is the practical deadline to remember?

Treat 25 May 2026 as the key first milestone if you are applying in the initial 2026 round. The NOFO uses recurring NIH cycle dates, and teams should plan around the earliest suitable cycle that matches readiness.

Official links and source documents

• Official NOFO page (source of this opportunity):
  • https://files.simpler.grants.gov/opportunities/3df028f3-f97a-4cdf-9359-1c6515d091ce/attachments/32095b88-f093-488f-aa71-1b39ce517067/PA-26-002-Full-Announcement.html
• NIH ASSIST system (submission):
  • https://public.era.nih.gov
• eRA Commons:
  • https://era.nih.gov
• Grants.gov:
  • https://www.grants.gov
• NIH Multi-project application guidance:
  • https://grants.nih.gov/grants/how-to-apply-application-guide

What to monitor after publishing this page

Because this opportunity is open across recurring cycles, monitor these sources on each cycle:

• The official NIH NOFO page for any notices that adjust instructions or deadlines.
• IC-specific guidance from the intended NIH institute or center.
• Funding notices, if any, for policy changes linked to international awards and registration.
• Any updates on required forms or PF5 technical instructions in the NIH application guide.

In practice, this is a high-control, high-complexity opportunity. It rewards teams that treat the collaboration structure as an advantage and build the administration, governance, and scientific narrative as one integrated system.